相关实验视频

Updated: Jun 23, 2025

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Published on: February 27, 2016

作为肺腺癌的潜在生物标志物SIRT2:对免疫透的影响

Guining Zhang¹, Shuyu Lu², Zhiling Ren³

¹Department of Scientific Research, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, Guangxi, China.

Molecular biotechnology

|June 20, 2024

概括

减少SIRT2表达与肺腺癌 (LUAD) 的预后不佳有关. 这项研究强调SIRT2作为LUAD的潜在生物标志物和免疫治疗的目标.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

赛尔图因2 (SIRT2) 与非小细胞肺癌 (NSCLC) 的发展和代谢有关.
目前尚不清楚SIRT2在肺腺癌 (LUAD) 进展和预后中的具体作用.

研究的目的:

调查SIRT2在LUAD中的表达,预后价值和免疫治疗相关性.
探索SIRT2在LUAD中的生物功能及其与免疫透的关联.

主要方法:

使用TIMER 2.0,UALCAN和HPA数据库对SIRT2mRNA和蛋白质水平的分析.
通过KM Plotter和TCGA数据库进行预测相关性评估.
使用GSEA对免疫透和功能丰富的评估.

主要成果:

与正常组织相比,LUAD组织中的SIRT2表达显著降低.
较低的SIRT2表达与不良预后结果相关,并与临床病理特征相关.
SIRT2与免疫细胞透 (NK细胞,巨细胞,树突细胞) 和免疫评分正相关.

结论:

SIRT2 作为 LUAD 的潜在预后生物标志物.
减少SIRT2表达表明在LUAD进展中发挥作用,并影响免疫疗法反应.
SIRT2代表了对LUAD治疗的潜在新疗法标.

关键词:

生物功能生物功能表达方式表达方式表达免疫反应的免疫反应.肺腺癌 (LUAD) 是一种肺腺癌.在SIRT2中使用SIRT2.

更多相关视频

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...